Promising Brain Cancer Drug Shows Mixed Results in Late-Stage TrialBusiness PenMarch 25, 2025 March 25, 2025 A novel brain cancer treatment developed by CNS Pharmaceuticals (NASDAQ: CNSP) has shown mixed results in a late-stage clinical trial. The drug, Berubicin, did not...
